P Thongcharoen

Vaccination with ALVAC and AIDSVAX to Prevent HIV-1 Infection in Thailand

Supachai Rerks‐Ngarm, Punnee Pitisuttithum, Sorachai Nitayaphan et al. · New England Journal of Medicine · 2009 · 3K citations · Full text

Veterinary Medicine, Infectious Diseases, Preventive Medicine +12

Risk behaviour and time as covariates for efficacy of the HIV vaccine regimen ALVAC-HIV (vCP1521) and AIDSVAX B/E: a post-hoc analysis of the Thai phase 3 efficacy trial RV 144

Merlin L. Robb, Supachai Rerks‐Ngarm, Sorachai Nitayaphan et al. · The Lancet Infectious Diseases · 2012 · 215 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +14

The Thai Phase III Trial (RV144) Vaccine Regimen Induces T Cell Responses That Preferentially Target Epitopes within the V2 Region of HIV-1 Envelope

Mark de Souza, Silvia Ratto‐Kim, Weerawan Chuenarom et al. · The Journal of Immunology · 2012 · 140 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

Antibody-dependent cell-mediated cytotoxic responses in participants enrolled in a phase I/II ALVAC-HIV/AIDSVAX® B/E prime-boost HIV-1 vaccine trial in Thailand

Chitraporn Karnasuta, Robert Paris, Josephine H. Cox et al. · Vaccine · 2004 · 102 citations

Life Sciences, Immunology, Infectious Diseases +12

A Phase 1/2 Comparative Vaccine Trial of the Safety and Immunogenicity of a CRF01_AE (Subtype E) Candidate Vaccine

P Thongcharoen, Vinai Suriyanon, Robert Paris et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 2007 · 98 citations

Veterinary Medicine, Immunology, Infectious Diseases +17